세계의 면역분석 시장 : 동향, 기술, 성장 기회(2025년)

Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025

US $ 7,000 ￦ 9,842,000

Online Access (Single User License)

PDF 보고서를 1분이 열람(다운로드 불가)할 수 있는 라이선스입니다. 인쇄는 1회 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,060,000

Online Access & PDF Download (Unlimited Users)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

최신 보고서 "세계의 면역분석 시장 : 동향, 기술, 성장 기회(2025년)"는 체외진단(IVD) 산업에서 가장 중요한 부문 중 하나인 면역분석에 대한 상세한 분석과 2024년부터 2029년까지의 시장 추정 및 예측을 담고 있습니다. 항체와 항원의 상호작용을 통해 표적 분석물을 검출하는 진단 테스트인 면역분석은 임상 실험실 및 현장 진료(POC) 환경에서 단백질, 호르몬, 약물, 감염성 물질의 검출을 가능하게 하는 기초적인 도구입니다.

세계 면역분석 시장은 자동화, 소형화, 다중화, 바이오마커 탐색의 발전으로 계속 확대되고 있습니다. 면역분석은 성숙한 기술임에도 불구하고, 중앙 검사실에서 자가 검사 애플리케이션에 이르기까지 현대의 헬스케어 요구에 부응하기 위해 빠르게 진화하고 있습니다.

시장 세분화

설정별

• 중앙 실험실 기반 면역분석법:
  • 핵심 실험실에서 진단, 모니터링, 스크리닝에 사용됩니다.
  • 시장 매출 : 주요 기여 요인으로는 감염성 질환, 심장 마커, 종양 마커가 있습니다.
  • 주요 부문
    • 감염성 질환 마커
    • 심장 마커
    • 대사성 질환과 호르몬
    • 종양 마커
    • 자가면역 및 알레르기 검사
• POC(Point-of-Care) 면역분석:
  • 병원, 진료소, 소매점, 자가 검사의 측방유동 및 기타 신속 검사를 포함합니다.
  • 사용 편의성 및 접근성 분산으로 급성장 중
  • 주요 대상 부문
    • 감염성 질환
    • 호르몬/불임
    • 심장 마커
    • 종양학 및 FOBT
    • 독성학

질병 카테고리별 내역

• 감염성 질환 : HIV, 간염, MRSA, 성병, COVID-19, TORCH 등의 검사가 포함됩니다.
• 심장 마커 : 심부전 검사와 급성기 의료 검사에서 강세를 보이고 있습니다.
• 호르몬과 불임 : 실험실과 POC 모두 높은 이용률을 보이고 있습니다.
• 종양/종양 마커 : PSA, CEA, CA-125, AFP가 중심이며, 실험실 기반이 우세합니다.
• 독성학 및 약물 모니터링 : 통증 관리, 응급 의료, 약물 남용 프로그램에 사용됩니다.
• 자가면역과 알레르기 : 전신질환에 대한 새로운 타겟과 확장된 패널.
• 유전자 검사 : 산전 스크리닝 및 면역분석 플랫폼별 유전자 발현 프로파일링이 포함됩니다.
• 기타 새로운 영역 : 알츠하이머병, 소화기 질환, 이식 의료, 여성 건강(자간전증 등).

지역 동향 분석

• 선진 시장:
  • 북미와 서유럽은 첨단 의료 인프라와 첨단 진단법 도입으로 우위를 점하고 있습니다.
  • 선진 아시아태평양도 중요한 역할을 하고 있습니다.
• 신흥 시장 :
  • 라틴아메리카, 동유럽, 동남아시아, 아프리카에서는 집중형 진단이 제한적이기 때문에 면역분석이 접근성 확대의 열쇠가 될 수 있습니다.
  • 리소스가 제한된 환경에서는 측방유동과 자체 검사가 중요한 도구가 될 수 있습니다.

조사 방법 및 범위

이 보고서는 2024년부터 2029년까지의 세계 면역분석 시장을 달러 기준으로 조사하여 발표하였습니다. 이 보고서는 고처리 실험실 장비부터 신속 면역크로마토그래피 및 측방유동법을 포함한 수동 POC(Point-of-Care) 검사에 이르기까지 다양한 면역분석 기술을 분석합니다.

선진 지역(북미, 서유럽, 아시아태평양)에 주력하는 한편, 진단 서비스가 부족한 지역의 진단 접근성 확대에 있어 POC 검사의 중요성도 인식하고 있습니다.

시장 데이터는 소매 가격이나 상환 금액이 아닌 제조업체의 수익을 반영합니다. 장비 비용은 종종 검사당 가격 책정에 번들로 묶여 있기 때문에 부문 값은 일반적으로 검사량과 일치합니다.

본 보고서의 조사 결과는 1차 조사와 2차 조사를 종합한 결과입니다. 2차 자료는 공개 기업 및 자체 데이터베이스, 업계 보고서, 규제 당국 신고서, 기업 간행물, 학술지 등 다양한 출처에서 수집되었습니다. 이러한 출처를 통해 배경, 경쟁사 식별, 전략적 인사이트를 얻을 수 있었습니다.

조사를 검증하고 심화하기 위해 Kalorama는 경영진, 제품 및 마케팅 리더, 컨설턴트, 의료 전문가, 정부 대표 등 업계 전문가들과 30회 이상의 인터뷰를 진행했습니다. 이 인터뷰를 통해 시장 역학 및 트렌드에 대한 질적 인사이트를 얻을 수 있었습니다.

기업들에 대한 추가 접촉을 통해 매출, 시장 점유율, 제품 성능에 대한 구체적인 수치를 확보했습니다. 모든 데이터는 여러 출처와 대조하고, 가능한 한 공개 정보, 독자적인 인사이트, 전문가 피드백을 통해 검증되었습니다.

시장 규모와 예측은 2024년을 기준년으로 하고, 2029년까지의 예측은 과거 동향, 인구통계학적 변화, 기술 발전, 세계 시장 확대에 의해 뒷받침되고 있습니다. 경쟁 상황 분석은 2024년의 상황을 반영하고, 그 이후의 동향도 밝혀내고 있습니다.

목차

제1장 주요 요약

제2장 소개

• 면역분석의 역사와 미래
• 면역분석 기술은 계속 진화하고 있다

제3장 기술, 동향, 혁신

• 개요 - 면역분석
  • 화학발광 면역분석(CLIA)
  • 효소면역측정법(ELISA)
  • 형광면역측정법(FIA)
  • 면역조직화학(IHC)
  • 측방유동 면역분석(LFIA)
  • 방사면역측정법(RIA)
  • 웨스턴 블롯팅
• 면역분석 기술의 혁신과 최신 동향
• 개요 - 계기 플랫폼
  • 마이크로타이터 플레이트를 이용한 면역분석과 자동화
  • 면역분석 자동화
  • 플랫폼의 혁신 : 소형화, 미세유체, 멀티플렉스화
  • POC(Point of Care)와 소형 디바이스
  • 랩온어칩(LOC)과 바이오칩
  • 사례 : Veravas VeraBIND 테크놀러지
• 시료 종류
  • 혈액
  • 소변
  • 타액

제4장 설정별 시장 부문

• 중앙연구소
• 신속·POC(Point of Care) 검사

제5장 면역분석 진단 시장 용도별 동향

• 알레르기
• 자가면역질환
• 심장 마커
• 유전자 검사
• 감염증
• 실험실 기반 감염증 면역분석
  • 혈액 검사
  • 간염
  • 라임병
  • 신속 테스트와 POC 테스트
  • 레트로바이러스
  • 성감염증
  • ToRCH
  • COVID-19
  • 기타 감염증
• 대사장애와 기타 호르몬
  • 임신·생식 호르몬
  • 갑상선
• 종양학 - 종양 마커
  • 실험실 기반 종양 면역분석
• 독물학
  • 남용 약물
  • 치료 약물 모니터링
• 면역분석 질환 시장의 기타 질환 카테고리

제6장 면역분석 시장 기회와 과제

• 면역분석 시장 - 개요
• 면역분석 시장 성장 촉진요인과 과제
  • 성장 촉진요인
• 면역분석법 혁신의 새로운 분야
  • 위장장애
  • 이식 관리
  • 임신 중독증
  • 알츠하이머병
• 신흥 국제 시장
• 실험실 개발 테스트
• 인원 부족
• 면역분석 전망

제7장 면역분석 시장 분석

• 시장 개요와 시장 부문
• 경쟁 분석
• 지역별 면역분석 시장
  • 북미
  • 유럽
  • 아시아태평양
  • 기타 국가

제8장 기업 개요

• 1 Step Detect Associates, LLC
• Abbott Laboratories
• Abingdon Health, Ltd.
• Access Bio, Inc
• AccuBioTech Co, Ltd.
• ACON Laboratories, Inc
• AESKU. DIAGNOSTICS
• Aidian Oy
• Alfa Scientific Designs, Inc
• American Laboratory Products Company(ALPCO)
• Anbio Biotechnology
• ARKRAY, Inc
• Arlington Scientific, Inc.
• Artron Laboratories Inc.
• Associates of Cape Cod, Inc.(ACC)
• Autobio Diagnostics Co., Ltd
• Avioq, Inc
• Awareness Technology
• Beckman Coulter, Inc
• Becton Dickinson(BD)
• Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
• Bhat Bio-Tech India Private Ltd.(BBI)
• BioCheck, Inc.
• Biohit Oyj(Biohit Healthcare)
• bioLytical Laboratories
• BioMedomics, Inc.
• Biomerica
• bioMerieux SA
• BioPorto Diagnostics
• Bio-Rad Laboratories Inc.
• Bioscience(Tianjin) Diagnostic Technology Co., Ltd.
• Bio-Techne
• Biotron Diagnostics, Inc.
• Boditech Med Inc.
• Boson Biotech Co. Ltd
• BUHLMANN Laboratories AG
• Certest Biotec
• Chembio Diagnostic Systems, Inc.
• Clarity Diagnostics, LLC
• Confirm Biosciences
• CTK Biotech, Inc.
• Diagenics Group SE
• DIALAB GmbH
• Diametra
• DiaSorin S.p.A.
• DiaSource ImmunoAssays SA
• DiaSys Diagnostic Systems GmbH(Mindray)
• Diazyme Laboratories, Inc.
• Dr. Fooke-Achterrath Laboratorien GmbH
• Eiken Chemical Co Ltd.
• EKF Diagnostics Holdings plc
• ELITechGroup S.A.S.
• Eurobio Scientific
• Eurospital Spa
• EY Laboratories
• Fujirebio-US, Inc.
• GenBio
• Gold Standard Diagnostics
• Grifols International S.A.
• Hemosure, Inc.
• HYCOR Biomedical, Inc.
• Immuno-Mycologics, Inc.
• Immunosciences Lab, Inc.
• Immunostics, Inc
• InBios International, Inc.
• JAL Innovation PTE LTD
• Jant Pharmacal Corporation
• J Mitra & Co., Pvt. Ltd.
• KRONUS
• Kypha
• Labsystems Diagnostics Oy
• LamdaGen Corporation
• LifeSign, LLC
• Macherey-Nagel GmbH & Co. KG
• Medix Biochemica
• MedMira, Inc
• Mercodia AB
• Meridian BioScience, Inc
• Monobind, Inc
• Nano-Ditech Corporation
• Nexus Dx Inc
• Nova Biomedical, Corp.
• Oasis Diagnostics Corporation
• Operon
• OPKO Health, Inc
• OraSure Technologies, Inc.
• PixCell Medical Technologies
• Polymedco, Inc
• Precision Biosensor
• Preventis GmbH
• Princeton Biomeditech Corporation
• PTS Diagnostics
• Qualigen, Inc.
• Quanterix Corporation
• QuidelOrtho Corporation
• Radiometer Medical A/S
• Response Biomedical Corp.
• Reszon Diagnostics International Sdn. Bhd.
• Revvity
• Roche Diagnostic Corporation
• Savyon Diagnostics Ltd.
• Sekisui Diagnostics LLC
• Siemens Healthineers
• Syntron Bioresearch, Inc.
• Sysmex Corporation
• TECHLAB, Inc.
• Teco Diagnostics
• Thermo Fisher Scientific, Inc
• Tosoh Bioscience, Inc.
• Trinity Biotech PLC
• True Diagnostics
• VedaLab
• Vircell
• WAMA Diagnostica
• Werfen Group
• Zeus Scientific, Inc

ksm

영문 목차

영문목차

Kalorama Information's new report, "Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025", provides an in-depth analysis of one of the most pivotal segments of the in vitro diagnostics (IVD) industry with market estimates and forecasts spanning 2024-2029. Immunoassays-diagnostic tests that detect target analytes via antibody-antigen interactions-are foundational tools in clinical laboratories and point-of-care (POC) settings, enabling the detection of proteins, hormones, drugs, and infectious agents.

The global immunoassay market continues to expand, driven by advances in automation, miniaturization, multiplexing, and biomarker discovery. Despite being a mature technology, immunoassays are evolving rapidly to meet modern healthcare needs-from central labs to self-testing applications.

Market Segmentation

By Setting

• Centralized Lab-Based Immunoassays:
  • Used in core labs for diagnostics, monitoring, and screening.
  • Market Sales: Major contributors include infectious diseases, cardiac markers, and tumor markers.
  • Top segments covered:
    • Infectious Disease
    • Cardiac Markers
    • Metabolic Disorders & Hormones
    • Tumor Markers
    • Autoimmune & Allergy Testing
• Point-of-Care (POC) Immunoassays:
  • Includes lateral flow and other rapid tests in hospitals, clinics, retail settings, and self-testing.
  • Rapidly growing due to ease of use and decentralized access.
  • Top segments covered:
    • Infectious Disease
    • Hormone/Fertility
    • Cardiac Markers
    • Oncology & FOBT
    • Toxicology

Breakout By Disease Category

• Infectious Disease: Largest and most diverse segment; includes tests for HIV, hepatitis, MRSA, STDs, COVID-19, and TORCH.
• Cardiac Markers: Strong growth from heart failure and acute care testing.
• Hormones & Fertility: High usage in both labs and POC; includes reproductive and thyroid hormones.
• Oncology/Tumor Markers: Focus on PSA, CEA, CA-125, AFP with lab-based dominance.
• Toxicology & Drug Monitoring: Used in pain management, emergency medicine, and substance abuse programs.
• Autoimmune & Allergy: Emerging targets and expanded panels for systemic diseases.
• Genetic Testing: Includes prenatal screening and gene expression profiling via immunoassay platforms.
• Other Emerging Areas: Alzheimer's disease, gastrointestinal disorders, transplant medicine, and women's health (e.g., preeclampsia).

Analysis of Geographic Trends

• Developed Markets:
  • North America and Western Europe dominate due to high healthcare infrastructure and adoption of advanced diagnostics.
  • Developed Asia Pacific also plays a key role.
• Emerging Markets:
  • Immunoassays are key to expanding access in Latin America, Eastern Europe, Southeast Asia, and Africa, where centralized diagnostics are limited.
  • Lateral flow and self-testing are critical tools in resource-limited settings.

Scope and Methodology

This report presents the global immunoassay market in U.S. dollars, covering the years 2024 through 2029. It analyzes a wide range of immunoassay technologies, from high-throughput lab instruments to manual point-of-care (POC) tests, including rapid immunochromatographic or lateral flow formats.

The primary focus is on developed regions-North America, Western Europe, and developed Asia-Pacific-while also recognizing the importance of POC testing in expanding diagnostic access in underserved areas.

Market data reflects manufacturer revenue rather than retail prices or reimbursements. Segment values generally align with test volumes, as instrument costs are often bundled into per-test pricing.

A blend of primary and secondary research underpins the report's findings. Secondary sources included public and proprietary databases, industry reports, regulatory filings, company publications, and peer-reviewed journals. These sources provided context, competitor identification, and strategic insights.

To validate and deepen the research, Kalorama conducted over 30 interviews with industry experts such as executives, product and marketing leaders, consultants, healthcare professionals, and government representatives. These interviews provided qualitative insights into market dynamics and trends.

Additional outreach to companies yielded specific figures on revenue, market share, and product performance. All data were verified against multiple sources and, when possible, triangulated using public disclosures, proprietary insights, and expert feedback.

Market sizing and forecasts are based on 2024 as the base year, with projections through 2029 supported by historical trends, demographic shifts, technological advances, and global market expansion. Competitive analysis reflects the landscape in 2024, with forward-looking trends identified for subsequent years.

Table of Contents

Chapter 1: Executive Summary

• Overview
• Scope and Methodology
• Market Overview
  • Table 1-1: Global Immunoassay Market, 2024-2029 ($ million) [Lab-based, POC-based]
  • Figure 1-1: Global Immunoassay Market, 2024-2029 ($ million) [Lab-based, POC-based]
  • Figure 1-2: Global Immunoassay Market Share, 2024-2029 ($ million) [Lab-based, POC-based]
• Competitive Summary

Chapter 2: Introduction

• History and Future of Immunoassays
• Immunoassay Technology Continues to Evolve

Chapter 3: Technology, Trends, and Innovations

• Overview - Immunoassays
  • Table 3-1: Immunoassay Sensitivity, by Technology Type and Setting (Lab, POC) [CLIA, ELISA, FIA, IHC, LFIA, RIA]
  • Chemiluminescent Immunoassay (CLIA)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Fluoroimmunoassay (FIA)
  • Immunohistochemistry (IHC)
  • Lateral Flow Immunoassay (LFIA)
  • Radioimmunoassay (RIA)
  • Western Blotting
• Immunoassay Technology Innovations and Emerging Trends
• Overview - Instrument Platforms
  • Microtiter Plate-Based Immunoassays and Automation
  • Automation in Immunoassays
  • Platform Innovations: Miniaturization, Microfluidics, and Multiplexing
  • Point-of-Care (POC) and Miniaturized Devices
  • Lab-on-a-Chip (LOC) and Biochips
  • Case Example: Veravas VeraBIND Technology
    • Table 3-2: Selected Immunoassay Technologies
• Specimen Types
  • Blood
  • Urine
  • Saliva
    • Table 3-3: Selected Companies with Saliva or Oral-Fluid Collection Devices

Chapter 4: Market Segment by Setting

• Centralized Laboratories
  • Table 4-1: Global Lab-based Immunoassay Market, by Application Segment, 2024 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
  • Figure 4-1: Global Lab-based Immunoassay Market, by Application Segment, 2024 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
  • Figure 4-2: Global Lab-based Immunoassay Market Distribution, by Application Segment, 2024 (%) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
  • Companies Marketing to Centralized Laboratories
    • Table 4-2: Selected Companies Marketing Central Lab-Based Immunoassays Worldwide
• Rapid and Point-of-Care Testing
  • Table 4-3: Global POC-based Immunoassay Market, by Application Segment, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
  • Figure 4-3: Global POC-based Immunoassay Market, by Application Segment, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
  • Figure 4-4: Global POC-based Immunoassay Market Distribution, by Application, 2024 (%) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology, Toxicology, Other]
  • POC Testing in Hospitals
  • Physician's Office Laboratories and Clinics
  • Retail Clinics
  • Other Professional POC Testing
  • Self-Testing
  • Companies Marketing Immunoassay for POC Testing
    • Table 4-4: Selected Companies Marketing Immunoassay and/or Lateral Flow Tests for POC Worldwide

Chapter 5: Immunoassay Diagnostic Market Activity by Application

• Table 5-1: Immunoassay Market Disease Categories
• Allergy
  • Figure 5-1: Global Allergy Immunoassay Market, 2024-2029 ($ million)
  • Table 5-2: Selected Companies Marketing Immunoassays for Allergy Diagnostics
• Autoimmune Disease
  • Figure 5-2: Global Autoimmune Disease Immunoassay Market, 2024-2029 ($ million)
  • Table 5-3: Selected Autoantibodies Detected by Autoimmune Immunoassays
• Cardiac Markers
  • Figure 5-3: Global Cardiac Marker Immunoassay Market, 2024-2029 ($ million)
  • Table 5-4: Selected Cardiac Marker Immunoassays
  • Table 5-5: Selected Cardiac Marker Innovations
• Genetic Testing
  • Figure 5-4: Global Genetic Immunoassay Market, 2024-2029 ($ million)
• Infectious Disease
  • Figure 5-5: Global Infectious Disease Immunoassay Market, 2024-2029 ($ million)
• Lab-based Infectious Disease Immunoassays
  • Table 5-6: Global Lab-based Infectious Disease Immunoassay Sales, 2024 ($ million) [Blood banking, C. diff, Hepatitis, HIV, MRSA, Respiratory, STD, Staphylococci, TORCH, Other infectious diseases]
  • Figure 5-6: Global Lab-based Infectious Disease Immunoassay Sales, 2024 ($ million) [Blood banking, C. diff, Hepatitis, HIV, MRSA, Respiratory, STD, Staphylococci, TORCH, Other infectious diseases]
  • Figure 5-7: Global Lab-based Infectious Disease Immunoassay Market Share, 2024 (%) [Blood banking, C. diff, Hepatitis, HIV, MRSA, Respiratory, STD, Staphylococci, TORCH, Other infectious diseases]
  • Blood Screening
    • Table 5-7: Selected Infectious Disease Immunoassays
    • Table 5-8: Selected Companies Marketing Immunoassays for Infectious Disease
  • Hepatitis
  • Lyme Disease
  • Rapid and POC Testing
  • Retroviral
  • Sexually Transmitted Diseases
  • ToRCH
  • COVID-19
    • Table 5-9: Selected Antigen POC and Home Immunoassay Tests for SARS-CoV-2
  • Other Infectious Diseases
• Metabolic Disorders and Other Hormones
  • Figure 5-8: Global Metabolic and Hormone Disorder Immunoassay Market, 2024-2029 ($ million)
  • Table 5-10: Selected Metabolic and Other Hormone Immunoassays
  • Fertility/Pregnancy/Reproductive Hormones
    • Table 5-11: Selected Fertility and Reproductive Hormone Immunoassays
  • Thyroid
    • Table 5-12: Selected Thyroid Hormone Immunoassays
• Oncology - Tumor Markers
  • Figure 5-9: Global Oncology Immunoassay Market, 2024-2029 ($ million)
  • Lab-based Oncology Immunoassays
    • Table 5-13: Global Lab-based Tumor Marker Immunoassay Sales, 2024 ($ million) [AFP, CA-125, CEA, PSA, Others]
    • Figure 5-10: Global Lab-based Tumor Marker Immunoassay Sales, 2024 ($ million) [AFP, CA-125, CEA, PSA, Others]
    • Figure 5-11: Global Lab-based Tumor Marker Immunoassay Market Share, 2024 (%) [AFP, CA-125, CEA, PSA, Others]
    • Table 5-14: Selected Companies Marketing Immunoassays for Tumor Markers
    • Table 5-15: Selected Companies Marketing Metabolic Immunoassays
• Toxicology
  • Figure 5-12: Global Toxicology Marker Immunoassay Market, 2024-2029 ($ million)
  • Drugs of Abuse
    • Table 5-16: Selected Drugs of Abuse Immunoassays
  • Therapeutic Drug Monitoring
    • Table 5-17: Selected Therapeutic Drug Monitoring Immunoassays
• Other Disease Categories in Immunoassay Disease Market
  • Figure 5-13: Other Immunoassay Market, 2024-2029 ($ million)
  • Table 5-18: Selected Other Immunoassays

Chapter 6: Market Opportunities and Issues for Immunoassays

• Immunoassay Market - Overview
• Immunoassay Market Drivers and Challenges
  • Drivers
• New and Emerging Areas of Immunoassay Innovation
  • Gastrointestinal Disorders
    • Table 6-1: Selected Inflammatory Bowel Disease Test Innovations
  • Transplant Management
    • Table 6-2: Selected Immunoassays for Transplant Medicine
  • Preeclampsia
    • Table 6-3: Selected Women's Health Innovations
  • Alzheimer's Disease
    • Table 6-4: Selected Innovations for Alzheimer's Disease Immunoassays
    • Table 6-5: Selected Immunoassay Innovations
• Emerging International Markets
  • Table 6-6: Selected Companies Outside of North America, Europe, or Japan Marketing Immunoassays
• Lab-Developed Tests
• Staffing Shortages
• Outlook for Immunoassays

Chapter 7: Immunoassay Market Analysis

• Market Overview and Market Segments
  • Table 7-1: Global Immunoassay Market, by Laboratory Setting, 2024-2029 ($ million) [Lab-based, POC-based]
  • Figure 7-1: Global Immunoassay Market, by Laboratory Setting, 2024-2029 ($ million) [Lab-based, POC-based]
  • Figure 7-2: Global Immunoassay Market Segment Share, by Laboratory Setting, 2024 (%) [Lab-based, POC-based]
  • Central Lab-based Immunoassay Market
    • Table 7-2: Global Lab-based Immunoassay Market, by Application, 2024-2029 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Other]
    • Figure 7-3: Global Lab-based Immunoassay Market, by Application, 2024-2029 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Other]
  • Point of Care/Rapid Test Immunoassays by Disease Category
    • Table 7-3: Global POC Immunoassay Market Analysis, by Disease Category, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
    • Figure 7-4: Global POC Immunoassay Market Analysis, by Disease Category, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
    • Figure 7-5 Global POC Immunoassay Market Analysis, by Disease Category Market Share, 2024 (%) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
  • Immunoassay Market by Technology Type
    • Table 7-4: Global Immunoassay Market, by Technology Segment, 2024-2029 ($ million) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
    • Figure 7-6: Global Immunoassay Market, by Technology Segment, 2024-2029 ($ million) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
    • Table 7-5: Global Immunoassay Market Share, by Technology Segment, 2024 (%) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
    • Figure 7-7: Global Immunoassay Market Share, by Technology Segment, 2024 (%) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
• Competitive Analysis
  • Table 7-6: Global Immunoassay Market Analysis, by Competitor Revenues ($ million) and Market Share (%), 2024 [Abbott, Becton Dickinson, Bio-Rad, bioMerieux, Bruker - CALID, Danaher, DiaSorin, QuidelOrtho, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Others]
  • Figure 7-8: Global Immunoassay Market Analysis, by Competitor Revenues ($ million), 2024 [Abbott, Becton Dickinson, Bio-Rad, bioMerieux, Bruker - CALID, Danaher, DiaSorin, QuidelOrtho, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Others]
  • Figure 7-9: Global Immunoassay Market Analysis, by Competitor Market Share, 2024 (%) [Abbott, Becton Dickinson, Bio-Rad, bioMerieux, Bruker - CALID, Danaher, DiaSorin, QuidelOrtho, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Others]
• Immunoassay Market by Geographic Regions
  • Table 7-7: Immunoassay Market, by Geographic Region, 2024-2029 ($ million) [Asia Pacific, Europe, North America, Rest of World]
  • Figure 7-10: Immunoassay Market, by Geographic Region, 2024-2029 ($ million) [Asia Pacific, Europe, North America, Rest of World]
  • Figure 7-11: Immunoassay Market Share, by Geographic Region, 2024 (%) [Asia Pacific, Europe, North America, Rest of World]
  • North America
  • Europe
    • Table 7-8: Immunoassay Market, by European Geographic Region, 2024 ($ million) [France, Germany, Italy, Spain, United Kingdom, Others]
    • Figure 7-12: Immunoassay Market, by European Geographic Region, 2024 ($ million) [France, Germany, Italy, Spain, United Kingdom, Others]
    • Figure 7-13: Immunoassay Market Share, by European Geographic Region, 2024 (%) [France, Germany, Italy, Spain, United Kingdom, Others]
  • Asia Pacific
    • Table 7-9: Immunoassay Market, by Asia Pacific Geographic Region, 2024 ($ million) [China, India, Japan, Others]
    • Figure 7-14: Immunoassay Market, by Asia Pacific Geographic Region, 2024 ($ million) [China, India, Japan, Others]
    • Figure 7-15: Immunoassay Market Share, by Asia Pacific Geographic Region, 2024 (%) [China, India, Japan, Others]
  • Rest of World
    • Table 7-10: Immunoassay Market, by Rest of World Geographic Region, 2024 ($ million) [Brazil, Mexico, Saudi Arabia, South Africa, Turkey, Others]
    • Figure 7-16: Immunoassay Market, by Rest of World Geographic Region, 2024 ($ million) [Brazil, Mexico, Saudi Arabia, South Africa, Turkey, Others]
    • Figure 7-17: Immunoassay Market Share, by Rest of World Geographic Region, 2024 (%) [Brazil, Mexico, Saudi Arabia, South Africa, Turkey, Others]

Chapter 8: Company Profiles

• 1 Step Detect Associates, LLC
  • Table 8-1: 1-Step Detect Associates Corporate Summary
  • Company Overview
  • Products
• Abbott Laboratories
  • Table 8-2: Abbott Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 8-3: Abbott Revenues, 2023-2024 ($millions)
• Abingdon Health, Ltd.
  • Table 8-4: Abingdon Health Corporate Summary
  • Company Overview
  • Products
• Access Bio, Inc.
  • Table 8-5: Access Bio Summary
  • Company Overview
  • Products
• AccuBioTech Co, Ltd.
  • Table 8-6: AccuBioTech Corporate Summary
  • Company Overview
  • Products
• ACON Laboratories, Inc
  • Table 8-7: ACON Laboratories Corporate Summary
  • Company Overview
  • Products
• AESKU. DIAGNOSTICS
  • Table 8-8: AESKU.DIAGNOSTICS Corporate Summary
  • Company Overview
  • Products
• Aidian Oy
  • Table 8-9: Aidian Corporate Summary
  • Company Overview
  • Products
• Alfa Scientific Designs, Inc
  • Table 8-10: Alfa Scientific Design
  • Company Overview
  • Products
• American Laboratory Products Company (ALPCO)
  • Table 8-11: American Laboratory Products Corporate Summary
  • Company Overview
  • Products
• Anbio Biotechnology
  • Table 8-12: Anbio Biotechnology Corporate Summary
  • Company Overview
  • Products
• ARKRAY, Inc
  • Table 8-13: ARKRAY Corporate Summary
  • Company Overview
  • Products
• Arlington Scientific, Inc.
  • Table 8-14: Arlington Scientific Corporate Summary
  • Company Overview
  • Products
• Artron Laboratories Inc.
  • Table 8-15: Artron Laboratories Corporate Summary
  • Company Overview
  • Products
• Associates of Cape Cod, Inc. (ACC)
  • Table 8-16: Associates of Cape Cod Corporate Summary
  • Company Overview
  • Products
• Autobio Diagnostics Co., Ltd
  • Table 8-17: Autobio Diagnostics Corporate Summary
  • Company Overview
  • Products
• Avioq, Inc.
  • Table 8-18: Avioq Corporate Summary
  • Company Overview
  • Products
• Awareness Technology
  • Table 8-19: Awareness Technology Corporate Summary
  • Company Overview
  • Products
• Beckman Coulter, Inc
  • Table 8-20: Beckman Coulter Corporate Summary
  • Company Overview
  • Products
• Becton Dickinson (BD)
  • Table 8-21: BD Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 8-22: BD Corporation Revenue, 2023-2024 ($ million)
• Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Table 8-23: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
  • Company Overview
  • Products
• Bhat Bio-Tech India Private Ltd. (BBI)
  • Table 8-24: Bhat Bio-Tech India Private Corporate Summary
  • Company Overview
  • Products
• BioCheck, Inc.
  • Table 8-25: BioCheck Corporate Summary
  • Company Overview
  • Products
• Biohit Oyj (Biohit Healthcare)
  • Table 8-26: Biohit Oyj Corporate Summary
  • Company Overview
  • Products
• bioLytical Laboratories
  • Table 8-27: bioLytical Laboratories Corporate Summary
  • Company Overview
  • Products
• BioMedomics, Inc.
  • Table 8-28: BioMedomics Corporate Summary
  • Company Overview
  • Products
• Biomerica
  • Table 8-29: Biomerica Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 8-30: Biomerica Corporation Revenue, 2023-2024 ($ million)
• bioMerieux SA
  • Table 8-31: bioMerieux SA Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 8-32: bioMerieux Revenues, 2023-2024 (Euro- millions)
• BioPorto Diagnostics
  • Table 8-33: BioPorto Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 8-34: BioPorto Diagnostics Revenues, 2023-2024 (DKK millions)
• Bio-Rad Laboratories Inc.
  • Table 8-35: Bio-Rad Labs Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 8-36: Bio-Rad Corporation Revenue, 2023-2024 ($ million)
• Bioscience (Tianjin) Diagnostic Technology Co., Ltd.
  • Table 8-37: Bioscience (Tianjin) Diagnostic Technology Corporate Summary
  • Company Overview
  • Products
• Bio-Techne
  • Table 8-38: Bio-Techne Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 8-39: Bio-Techne, 2023-2024 ($ million)
• Biotron Diagnostics, Inc.
  • Table 8-40: Biotron Diagnostics Corporate Summary
  • Company Overview
  • Products
• Boditech Med Inc.
  • Table 8-41: Boditech Med Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 8-42: Boditech Med Revenues 2023-2024 (KRW billion)
• Boson Biotech Co. Ltd
  • Table 8-43: Boson Biotech Corporate Summary
  • Company Overview
  • Products
• BUHLMANN Laboratories AG
  • Table 8-44: BUHLMANN Laboratories Summary
  • Company Overview
  • Products
• Certest Biotec
  • Table 8-45: Certest Biotec Summary
  • Company Overview
  • Products
• Chembio Diagnostic Systems, Inc.
  • Table 8-46: Chembio Diagnostic Corporate Summary
  • Company Overview
  • Products
• Clarity Diagnostics, LLC
  • Table 8-47: Clarity Diagnostics Corporate Summary
  • Company Overview
  • Products
• Confirm Biosciences
  • Table 8-48: Confirm Biosciences Corporate Summary
  • Company Overview
  • Products
• CTK Biotech, Inc.
  • Table 8-49: CTK Biotech Corporate Summary
  • Company Overview
  • Products
• Diagenics Group SE
  • Table 8-50: Diagenics Group Corporate Summary
  • Company Overview
  • Products
• DIALAB GmbH
  • Table 8-51: DIALAB Summary
  • Company Overview
  • Products
• Diametra
  • Table 8-52: Diametra Corporate Summary
  • Company Overview
  • Products
• DiaSorin S.p.A.
  • Table 8-53: DiaSorin Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 8-54: DiaSorin 2023-2024 (Euro- thousand)
• DiaSource ImmunoAssays SA
  • Table 8-55: DiaSource ImmunoAssays Corporate Summary
  • Company Overview
  • Products
• DiaSys Diagnostic Systems GmbH (Mindray)
  • Table 8-56: DiaSys Diagnostic Systems Corporate Summary
  • Company Overview
  • Products
• Diazyme Laboratories, Inc.
  • Table 8-57: Diazyme Laboratories Corporate Summary
  • Company Overview
  • Products
• Dr. Fooke-Achterrath Laboratorien GmbH
  • Table 8-58: Dr. Fooke-Achterrath Laboratorien Corporate Summary
  • Company Overview
  • Products
• Eiken Chemical Co Ltd.
  • Table 8-59: Eiken Chemical Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 8-60: Eiken Chemical Revenues, 2023-2024 (million yen)
• EKF Diagnostics Holdings plc
  • Table 8-61: EKF Diagnostics Corporate Summary
  • Company Overview
  • Products
• ELITechGroup S.A.S.
  • Table 8-62: ELITechGroup Corporate Summary
  • Company Overview
  • Products
• Eurobio Scientific
  • Table 8-63: Eurobio Scientific Corporate Summary
  • Company Overview
  • Products
• Eurospital Spa
  • Table 8-64: Eurospital Summary
  • Company Overview
  • Products
• EY Laboratories
  • Table 8-65: EY Laboratories Summary
  • Company Overview
  • Products
• Fujirebio-US, Inc.
  • Table 8-66: Fujirebio Corporate Summary
  • Company Overview
  • Products
• GenBio
  • Table 8-67: GenBio Corporate Summary
  • Company Overview
  • Products
• Gold Standard Diagnostics
  • Table 8-68: Gold Standard Diagnostics Corporate Summary
  • Company Overview
  • Products
• Grifols International S.A.
  • Table 8-69: Grifols International S.A. Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 8-70: Grifols Revenue, 2023-2024 (Euro- million)
• Hemosure, Inc.
  • Table 8-71: Hemosure Corporate Summary
  • Company Overview
  • Products
• HYCOR Biomedical, Inc.
  • Table 8-72: HYCOR Biomedical Corporate Summary
  • Company Overview
  • Products
• Immuno-Mycologics, Inc.
  • Table 8-73: Immuno-Mycologics Corporate Summary
  • Company Overview
  • Products
• Immunosciences Lab, Inc.
  • Table 8-74: Immunosciences Lab Corporate Summary
  • Company Overview
  • Products
• Immunostics, Inc
  • Table 8-75: Immunostics Corporate Summary
  • Company Overview
  • Products
• InBios International, Inc.
  • Table 8-76: InBios Corporate Summary
  • Company Overview
  • Products
• JAL Innovation PTE LTD
  • Table 8-77: JAL Innovation Corporate Summary
  • Company Overview
  • Products
• Jant Pharmacal Corporation
  • Table 8-78: Jant Pharmacal Summary
  • Company Overview
  • Products
• J Mitra & Co., Pvt. Ltd.
  • Table 8-79: J Mitra Corporate Summary
  • Company Overview
  • Products
• KRONUS
  • Table 8-80: KRONUS Corporate Summary
  • Company Overview
  • Products
• Kypha
  • Table 8-81: Kypha Corporate Summary
  • Company Overview
  • Products
• Labsystems Diagnostics Oy
  • Table 8-82: Labsystems Diagnostics Corporate Summary
  • Company Overview
  • Products
• LamdaGen Corporation
  • Table 8-83: LamdaGen Corporate Summary
  • Company Overview
  • Products
• LifeSign, LLC
  • Table 8-84: LifeSign Summary
  • Company Overview
  • Products
• Macherey-Nagel GmbH & Co. KG
  • Table 8-85: Macherey-Nagel Corporate Summary
  • Company Overview
  • Products
• Medix Biochemica
  • Table 8-86: Medix Biochemica Summary
  • Company Overview
  • Products
• MedMira, Inc
  • Table 8-87: MedMira Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 8-88: MedMira, Revenues 2023-2024 ($ thousands)
• Mercodia AB
  • Table 8-89: Mercodia AB Summary
  • Company Overview
  • Products
• Meridian BioScience, Inc
  • Table 8-90: Meridian BioScience Corporate Summary
  • Company Overview
  • Products
• Monobind, Inc
  • Table 8-91: Monobind Corporate Summary
  • Company Overview
  • Products
• Nano-Ditech Corporation
  • Table 8-92: Nano-Ditech Corporate Summary
  • Company Overview
  • Products
• Nexus Dx Inc
  • Table 8-93: Nexus Dx Corporate Summary
  • Company Overview
  • Products
• Nova Biomedical, Corp.
  • Table 8-94: Nova Biomedical Corporate Summary
  • Company Overview
  • Products
• Oasis Diagnostics Corporation
  • Table 8-95: Oasis Diagnostics Corporate Summary
  • Company Overview
  • Products
• Operon
  • Table 8-96: Operon Corporate Summary
  • Company Overview
  • Products
• OPKO Health, Inc
  • Table 8-97: OPKO Health Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 8-98: OPKO Health Revenues, 2023-2024 ($ million)
• OraSure Technologies, Inc.
  • Table 8-99: OraSure Technologies Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 8-100: OraSure Revenues, 2023-2024 ($ million)
• PixCell Medical Technologies
  • Table 8-101: PixCell Corporate Summary
  • Company Overview
  • Products
• Polymedco, Inc
  • Table 8-102: Polymedco Corporate Summary
  • Company Overview
  • Products
• Precision Biosensor
  • Table 8-103: Precision Biosensor Corporate Summary
  • Company Overview
  • Products
• Preventis GmbH
  • Table 8-104: Preventis Corporate Summary
  • Company Overview
  • Products
• Princeton Biomeditech Corporation
  • Table 8-105: Princeton Biomeditech Corporate Summary
  • Company Overview
  • Products
• PTS Diagnostics
  • Table 8-106: PTS Corporate Summary
  • Company Overview
  • Products
• Qualigen, Inc.
  • Table 8-107: Qualigen Corporate Summary
  • Company Overview
  • Products
• Quanterix Corporation
  • Table 8-108: Quanterix Corporate Summary
  • Company Overview
  • Products
• QuidelOrtho Corporation
  • Table 8-109: QuidelOrtho Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 8-110: QuidelOrtho Revenues, 2023-2024 ($ million)
• Radiometer Medical A/S
  • Table 8-111: Radiometer Medical Corporate Summary
  • Company Overview
  • Products
• Response Biomedical Corp.
  • Table 8-112: Response Biomedical Corporate Summary
  • Company Overview
  • Products
• Reszon Diagnostics International Sdn. Bhd.
  • Table 8-113: Reszon Diagnostics Corporate Summary
  • Company Overview
  • Products
• Revvity
  • Table 8-114: Revvity Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 8-115: Revvity Revenues, 2023-2024 ($ million)
• Roche Diagnostic Corporation
  • Table 8-116: Roche Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 8-117: Roche Diagnostics Revenue, 2023-2024 (CHF millions)
• Savyon Diagnostics Ltd.
  • Table 8-118: Savyon Diagnostics Summary
  • Company Overview
  • Products
• Sekisui Diagnostics LLC
  • Table 8-119: Sekisui Diagnostics Corporate Summary
  • Company Overview
  • Products
• Siemens Healthineers
  • Table 8-120: Siemens Healthineers Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 8-121: Siemens Healthineers Revenue, 2023-2024 (Euro- millions)
• Syntron Bioresearch, Inc.
  • Table 8-122: Syntron Bioresearch Corporate Summary
  • Company Overview
  • Products
• Sysmex Corporation
  • Table 8-123: Sysmex Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 8-124: Sysmex Revenues, 2023-2024 (billion yen)
• TECHLAB, Inc.
  • Table 8-125: TECHLAB Corporate Summary
  • Company Overview
  • Products
• Teco Diagnostics
  • Table 8-126: Teco Diagnostics Corporate Summary
  • Company Overview
  • Products
• Thermo Fisher Scientific, Inc
  • Table 8-127: Thermo Fisher Scientific Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 8-128: Thermo Fisher Scientific Revenues, 2023-2024 ($ million)
• Tosoh Bioscience, Inc.
  • Table 8-129: Tosoh Bioscience Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 8-130: Tosoh Corporation Revenue, 2023-2024 (billion yen)
• Trinity Biotech PLC
  • Table 8-131: Trinity Biotech Corporate Summary
  • Company Overview
  • Products
• True Diagnostics
  • Table 8-132: True Diagnostics Corporate Summary
  • Company Overview
  • Products
• VedaLab
  • Table 8-133: VedaLab Corporate Summary
  • Company Overview
  • Products
• Vircell
  • Table 8-134: Vircell Corporate Summary
  • Company Overview
  • Products
• WAMA Diagnostica
  • Table 8-135: WAMA Diagnostica Corporate Summary
  • Company Overview
  • Products
• Werfen Group
  • Table 8-136: Werfen Group Corporate Summary
  • Company Overview
  • Products
• Zeus Scientific, Inc.
  • Table 8-137: Zeus Scientific Corporate Summary
  • Company Overview
  • Products

관련자료